Opko Health
OPK
226 hedge funds and large institutions have $191M invested in Opko Health in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 50 increasing their positions, 63 reducing their positions, and 33 closing their positions.
30% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 33
4% more funds holding
Funds holding: 218 → 226 (+8)
0.56% more ownership
Funds ownership: 22.22% → 22.78% (+0.56%)
21% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 63
26% less capital invested
Capital invested by funds: $259M → $191M (-$68.6M)
90% less call options, than puts
Call options by funds: $7.69M | Put options by funds: $75.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.94M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.58M |
| 3 |
Renaissance Technologies
New York
|
+$1.38M |
| 4 |
HF
HRT Financial
New York
|
+$1.37M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$3.94M |
| 3 |
BlackRock
New York
|
-$3.74M |
| 4 |
D.E. Shaw & Co
New York
|
-$3.2M |
| 5 |
Morgan Stanley
New York
|
-$2.44M |
OPK Hedge Fund Activity: Q1 2024 in Review
226 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q1 2024, worth a combined $191M — down 26% from $259M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new OPK positions and 33 closed out — a net gain of 10 holders — while 50 added to existing stakes and 63 trimmed.
The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $4.94M. The largest seller was Vanguard Group, cutting an estimated $10.3M.
- 226 institutional investors held Opko Health (OPK) as of Q1 2024, up from 218 in Q4 2023.
- Funds reported $191M of Opko Health stock for Q1 2024, down 26% quarter-over-quarter.
- 43 funds opened new Opko Health positions in Q1 2024 and 33 closed out, a net change of +10 holders.
- The largest Opko Health buyer in Q1 2024 was Rubric Capital Management (New York), an estimated $4.94M added.
- The largest Opko Health seller in Q1 2024 was Vanguard Group, an estimated $10.3M sold.
Based on aggregated 13F filings for Q1 2024.